期刊文献+

白介素-1β在缓激肽开放血脑屏障过程中的作用及其机制 被引量:7

Effect and mechanism of interleukin-1β in process of opening the blood-brain barrier by bradykinin
下载PDF
导出
摘要 目的探讨白介素-1β(IL-1β)在缓激肽(BK)开放血脑屏障(BBB)过程中的作用及其机制。方法缓激肽处理C6细胞后,动态观察培养液中IL-1β含量(放射免疫法)、C6细胞内热休克因子1(HSF1)蛋白的表达(Western blot法)及IL-1β的mRNA水平(RT-PCR法)。利用伊文思蓝检测C6恶性胶质瘤大鼠经颈内动脉给予IL-1β及缓激肽后血脑屏障的通透性。结果缓激肽作用于C6细胞后,培养液中IL-1β的含量明显增加,于120 min含量最多,其后开始减少。C6细胞内HSF1的表达及IL-1β的mRNA水平也在给予缓激肽后明显增加,并分别于干预后的30 min和60 min达高峰后逐渐减少。缓激肽与IL-1β单独作用于C6动物后均可引起胶质瘤大鼠的血脑屏障通透性增加,且IL-1β对肿瘤模型动物血脑屏障通透性的影响与C6细胞培养液中IL-1β的含量相一致。结论 IL-1β可能介导了缓激肽开放血脑屏障的作用,此作用可能是由于缓激肽诱导C6细胞内HSF1的表达增加,增加的HSF1促进神经胶质瘤细胞释放IL-1β所致。 Aim To investigate the effects of interleukin-1β(IL-1β) in process of opening blood-brain barrier(BBB) by bradykinin(BK) and its mechanism.Methods Contents of IL-1β in nutrient fluid(radioimmunity method),HSF1 protein expression(by Western blot) and levels of IL-1β the mRNA(by RT-PCR method) for C6 cells were dynamically observed,after BK treatment.Using Evans blue was applied to detect permeability of BBB after intracarotid infusion of IL-1β for C6 rats.Results For C6 cells,contents of IL-1β in the nutrient fluid were obviously increased after BK treatment and achieved the peak at 120 min,also BK significantly increased expressions of HSF1 and levels of IL-1β mRNA in C6 cells and reached the peak at 30 min and 60 min,separately.Permeability of BBB of C6 animals was in conformity with concentrations of IL-1β in nutrient fluid after BK treatment.Conclusion The IL-1β may mediate the effects of opening the BBB by bradykinin,which may be related with increased HSF1 expression caused by BK and the increased HSF1 promoted neurospongioma cell to release IL-1β.
出处 《中国药理学通报》 CAS CSCD 北大核心 2012年第1期58-61,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 81101912) 国家教育部新教师基金(No 20102134120007) 河北省卫生厅科研基金项目(No 20100464 20110165) 河北联合大学博士启动基金项目(No BS09012) 河北联合大学大学生创新性实验计划项目(No X2011035) 辽宁省博士启动基金(No20101109)
关键词 白介素-1Β 热休克因子1 缓激肽 血脑屏障 血肿瘤屏障 胶质瘤 interleukin-1β heat shock factor 1 bradykinin blood-brain barrier blood-tumor barrier glioma
  • 相关文献

参考文献4

  • 1Uchida M,Chen Z,Liu Y,et al.Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood-brain tumor barrier permeability increase[J].Neurol Res,2002,24(8):739-46.
  • 2秦丽娟,谷艳婷,薛一雪.缓激肽开放血瘤屏障过程中诱发快速耐受性的机制探讨[J].中国药理学通报,2006,22(12):1466-1470. 被引量:7
  • 3Emerich D F,Dean R L,Osborn C,et al.The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier:from concept to clinical evaluation[J].Clin Pharmacokinet,2001,40(2):105-23.
  • 4Thompson E M,Frenkel E P,Neuwelt E A.The paradoxical effect of bevacizumab in the therapy of malignant gliomas[J].Neurology,2011,76(1):87-93.

二级参考文献2

共引文献6

同被引文献129

引证文献7

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部